Ferrari, C.

patient treatment response hepatitis t-cell genotype therapy study kinetic hepatitis c stage liver score hepatitis c virus ribavirin virus plasma outcome guci score ishak hcv-speci treatment outcome group cirrhosis hcv rna signi hla-a fibrosis frequency peptide analysis value result figure fi rst month baseline t-cell lines decline interferon brosi t-cell response decay hla-a 2 peginterferon hcv-rna expansion ficant non-rvr proliferative t-cell responses university replication fi brosis genotype 1 control index proliferative level tetramer biopsy –liver pancreas point count hepatology infection time points 0.33 hcv genotype 1 liver fibrosis table hcv replication non-rvr patients disease control group correlation rvr patients trial ifn -␥ production cd 8 analysis cytotoxic blood